Literature DB >> 10219808

Recurrent nasopharyngeal carcinoma: the puzzles of long latency.

A W Lee1, W Foo, S C Law, Y F Poon, W M Sze, S K O, S Y Tung, R Chappell, W H Lau, J H Ho.   

Abstract

PURPOSE: To study the peculiar characteristics of relapses with long latency following radical treatment for nasopharyngeal carcinoma. METHODS AND MATERIALS: 847 patients with nasopharyngeal recurrence were retrospectively studied, focusing on the independent effects of latency on different outcome aspects and its relationship with other prognostic factors.
RESULTS: The proportion of recurrence with latency <2 years (Group A), 2-<5 years (Group B), and 25 years (Group C) were 52%, 39%, and 9%, respectively. A higher proportion of Group C originated from patients with node-negative early primary, but fewer of them were still confined within the nasopharynx at detection of recurrence. There was no significant difference in the choice of salvage modality, but among those reirradiated, more of Group C were treated with external beams to a higher dose. The difference in local salvage rate was not statistically significant, but the 5-year distant failure-free rates of the 3 groups were 57%, 67%, and 83%, respectively; and the corresponding disease-specific survival (DSS) were 14%, 20%, and 35%. Multivariate analysis confirmed the independent significance of latency in predicting distant failure (hazard ratio = 0.81 per year, p < 0.01) and cancer deaths (hazard ratio = 0.90 per year, p < 0.01).
CONCLUSIONS: Nasopharyngeal recurrence with long latency showed different natural behavior: the prognosis was significantly better due to lower risk of distant failure.

Entities:  

Mesh:

Year:  1999        PMID: 10219808     DOI: 10.1016/s0360-3016(98)00524-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge.

Authors:  Tao Xu; J Tang; M Gu; L Liu; W Wei; H Yang
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

2.  Diffusion-Weighted Imaging of Nasopharyngeal Carcinoma: Can Pretreatment DWI Predict Local Failure Based on Long-Term Outcome?

Authors:  B K H Law; A D King; K S Bhatia; A T Ahuja; M K M Kam; B B Ma; Q Y Ai; F K F Mo; J Yuan; D K W Yeung
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-05       Impact factor: 3.825

3.  Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area.

Authors:  Jia-Xin Li; Tai-Xiang Lu; Ying Huang; Fei Han
Journal:  ScientificWorldJournal       Date:  2012-02-01

4.  Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma.

Authors:  Tao Xu; Bojin Su; Chunhua Wang; Sumei Wang; Hecheng Huang; Yunbao Pan; Donghui Wang; Weihong Wei; François X Claret; Huiling Yang
Journal:  Oncol Rep       Date:  2015-01-20       Impact factor: 3.906

5.  Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up.

Authors:  Shang-Yin Wu; Yuan-Hua Wu; Ming-Wei Yang; Wei-Ting Hsueh; Jenn-Ren Hsiao; Sen-Tien Tsai; Kwang-Yu Chang; Jeffrey S Chang; Chia-Jui Yen
Journal:  BMC Cancer       Date:  2014-10-28       Impact factor: 4.430

Review 6.  Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic.

Authors:  Michaela Svajdova; Marian Sicak; Pavol Dubinsky; Marek Slavik; Pavel Slampa; Tomas Kazda
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

7.  Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency.

Authors:  Yung-Hsuan Chen; Sheng-Dean Luo; Shao-Chun Wu; Ching-Nung Wu; Tai-Jan Chiu; Yu-Ming Wang; Yao-Hsu Yang; Wei-Chih Chen
Journal:  Cancers (Basel)       Date:  2022-08-04       Impact factor: 6.575

Review 8.  Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer.

Authors:  Maarten A M Wildeman; Heike J Nyst; Baris Karakullukcu; Bing I Tan
Journal:  Head Neck Oncol       Date:  2009-12-17

Review 9.  Solitary splenic metastasis from nasopharyngeal carcinoma: a case report and systematic review of the literature.

Authors:  Pietro Genova; Francesco Brunetti; Emilie Bequignon; Filippo Landi; Vincenzo Lizzi; Francesco Esposito; Cecile Charpy; Julien Calderaro; Daniel Azoulay; Nicola de'Angelis
Journal:  World J Surg Oncol       Date:  2016-07-15       Impact factor: 2.754

10.  Correlation of PET-CT, MRI and histopathology findings in the follow-up of patients with nasopharyngeal cancer.

Authors:  Semih Ak; Caner Kiliç; Samet Özlügedik
Journal:  Braz J Otorhinolaryngol       Date:  2020-01-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.